查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470776

局部止血剂市场：按产品、配方、应用和最终用途 - 全球预测 2024-2030

Topical Hemostat Market by Product, Formulation, Application, End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年外用止血剂市场规模为21.2亿美元，预计2024年将达22.6亿美元，2030年将达33.6亿美元，复合年增长率为6.80%。

外用止血剂是指用于促进止血的产品。当直接涂布伤口或手术部位时，它可以防止过度出血并促进血块形成。局部止血剂用于各种医疗环境，从急诊和外科手术到慢性伤口处理。外用止血剂含有促进人体自然凝血过程或提供物理屏障以帮助抑制血液的活性物质。由于人口老化和慢性病增加，全球手术数量增加推动了该市场的发展。然而，先进止血材料的高成本以及与使用某些止血材料相关的潜在併发症可能会限制其应用并限制其可用性。然而，能够模仿自然止血的合成和生物活性材料的开拓以及新兴市场止血剂开发中奈米技术的使用预计将为市场提供利润丰厚的机会。

主要市场统计
基准年[2023] 21.2亿美元
预测年份 [2024] 22.6亿美元
预测年份 [2030] 33.6亿美元
复合年增长率（%） 6.80%

由于预防产品感染疾病等其他好处，外用止血剂的合併使用正在迅速增加。

基于胶原蛋白的局部止血剂源自于动物胶原蛋白，并透过提供促进凝块形成的基质来促进止血。胶原蛋白吸引并活化血小板，促进自然凝血连锁。这些产品型态多种形式，包括海绵、粉末和薄膜，用于各种手术环境中控制出血。组合局部止血剂结合了多种止血剂或机制以增强其有效性。它通常将胶原蛋白或明胶等物理基质与凝血酶和抗生素等促凝血物质结合以预防感染。此类多效产品同时提供控制出血和控制感染等其他益处，使其适合在手术领域更困难的出血情况下使用。明胶局部止血剂由猪或牛来源的明胶组成，通常呈现颗粒、发泡体或压缩海绵形式。这些止血材料提供了吸收血液并将凝血因子浓缩在出血部位的物理基质。明胶止血剂由于其有效性和易于使用而常用于手术和紧急情况。氧化再生纤维素基止血材料（外用止血剂）是透过对植物来源的纤维素进行化学处理而製成的，以提高其止血性能。这些产品提供凝血基质，降低伤口周围的 pH 值，并有助于止血过程。基于凝血酶的局部止血剂含有凝血酶，这是一种将纤维蛋白原转化为纤维蛋白的酶，诱导血块形成。这些止血剂由人类、牛或重组凝血酶製成，通常与其他材料（例如明胶或胶原蛋白垫片）结合使用。当手动压力不足或不切实际时，这种类型的止血剂对于控制出血特别有用。

配方：基质和凝胶止血材料越来越多地使用，因为它们能够适应不规则的伤口表面。

基质和凝胶止血剂是生物可吸收剂，其工作原理是提供支撑稳定血栓形成的物理支架。它们通常含有天然或合成物质，如胶原蛋白、明胶和纤维素。这些物质可与凝血酶和其他活性凝血剂结合，增强止血效果。粉状止血剂由颗粒状或绒毛状材料组成，黏附在伤口部位并透过脱水机制和凝血因子浓缩来帮助凝血。通常使用高岭土、沸石和其他矿物质等活性成分。它们特别有利，因为它们易于应用于出血表面，可用于微创手术，并且可以使用施用器或气腹进行应用。片状止血器和垫片止血器通常是止血材料的扁平结构，设计用于直接放置在出血组织表面上。常用的材料有氧化再生纤维素（ORC）、聚乙二醇（PEG）聚合物和胶原蛋白等。这些材料通常是优选的，因为它们易于处理，可以切割成所需的形状，并且适合提供促进凝块形成的机械屏障。海绵止血剂由明胶或胶原蛋白等可吸收材料製成，具有多孔结构，可为凝块形成提供机械支撑，并为血小板黏附和聚集提供基质。这些止血材料常用于各种外科手术，可应用于渗出表面或填充难以控制出血的空腔。

应用局部止血剂在心血管手术的重要用途

在心血管手术中，局部止血剂广泛用于控制血管吻合、移植部位和心臟组织的出血。它对于高风险患者的促进止血起着至关重要的作用，并且在准确的止血管理对于防止出血过多、血肿形成以及因出血而再次手术等併发症至关重要的情况下发挥着至关重要的作用。普通手术涉及多种手术，其中使用局部止血剂来控製手术部位的出血。这些药物可控製手术期间的出血，无论是开放性手术或腹腔镜手术。它可用于多种组织和器官，透过使手术野更加干燥，有望提高手术效果并缩短手术时间。肝臟和脾臟的撕裂通常会导致大量出血，因为这些器官是血管性的。在这种情况下，局部止血剂对于控制出血至关重要，可以快速止血以稳定患者的病情。整形外科手术，尤其是涉及关节关节重建和截骨术的手术，可能会导致大量出血。局部止血剂用于止血骨表面和软组织，可以减少术中出血，最大限度地减少术后瘀伤和血肿，并缩短癒合时间。在重组手术中，仔细止血对于确保移植物的活力和美观效果至关重要。局部止血剂可控制供体和受体部位的出血，最大限度地减少失血并降低术后併发症的风险，例如影响重组成功的血清肿和血肿形成。

最终用途：医院局部止血剂使用的演变

外用止血剂用于医院的各个科室，例如急诊室和手术室，特别是在心血管外科、整形外科和器官移植等高出血风险的手术中。在医院中，止血材料用于各种手术，从复杂手术到常规手术，因此通常需要稳定的止血材料供应，这使其成为製造商的重要市场。疗养院使用的局部止血剂主要用于需要小型手术或侵入性手术的老年族群。儘管疗养院的使用量远低于医院，但需要各种止血剂来适应因老龄化相关併发症而出血风险增加的患者。门诊手术中心是进行不需要住院的手术的专业设施。这些中心强调手术病例的效率和快速週转，通常需要速效局部止血剂来提高患者吞吐量并缩短手术时间。整容手术、微创手术等择期手术经常在这些中心进行，导致对止血材料的需求稳定。

区域洞察

在医疗基础设施、高人均医疗成本以及对先进外科手术的关注的支持下，美洲局部止血剂市场呈现强劲成长。此外，外科手术的普及和先进伤口管理推动的消费者需求正在推动市场成长，因为人们对局部止血剂的有效性的认识很高，并且医疗保健提供者准备采用新技术。最近的投资主要集中在美洲开发高度生物相容性和生物分解性的止血材料。欧盟 (EU) 拥有完善的医疗保健系统，强调病人安全和高标准护理，这推动了欧洲对局部止血剂的需求。大型製药公司的存在和对研究的大量投资为市场成长创造了有利的环境。同时，由于消费者对先进医疗产品的认识以及与医疗基础设施和私人医疗保健行业的开拓相关的需求不断增长，中东和非洲的市场正在扩大。这些地区的投资和倡议着重于建立医疗保健服务的能力，包括采用有效的手术辅助器具，例如外用止血剂。由于亚太地区人口众多、经济不断增长以及对医疗保健创新的投资，亚太地区代表了一个多元化且快速扩张的局部止血剂市场。此外，政府的支持和对医疗保健技术自给自足的关注正在推动市场成长，从而带动本地製造和创新的激增。亚太地区的最新专利反映出，考虑到经济和医疗保健服务的限制，开发适合当地市场的创新止血剂的措施。

FPNV定位矩阵

FPNV定位矩阵对于评估外用止血剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对局部止血剂市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争力评估及资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.局部止血剂市场规模及预测是多少？

2.在外用止血剂市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.外用止血剂市场的技术趋势和法规结构是什么？

4.局部止血剂市场主要厂商的市场占有率是多少？

5. 进入局部止血剂市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于人口老化和慢性病的蔓延，手术数量不断增加。
      • 医疗监管机构的有利产品核可
    • 抑制因素
      • 与局部止血产品相关的高成本
    • 机会
      • 正在进行研发以推出新型外用止血剂
      • 整合奈米技术开发更有效率的局部剂
    • 任务
      • 与使用局部止血剂相关的操作限制和感染风险
  • 市场区隔分析
    • 产品：由于减少感染等额外好处，复合局部止血剂的采用正在迅速增加。
    • 配方：基质和凝胶止血剂的使用正在扩大，因为它们能够贴合不规则的伤口表面。
    • 应用：局部止血剂在心血管手术的重要用途
    • 最终用途：医院局部止血剂使用的演变
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章局部止血剂市场：副产品

  • 胶原蛋白局部止血剂
  • 复方局部止血剂
  • 明胶局部止血剂
  • 氧化再生纤维素局部止血剂
  • 基于凝血酶的局部止血剂

第七章 处方外用止血剂市场

  • 基质和凝胶止血剂
  • 粉末止血剂
  • 片材和垫片止血剂
  • 海绵止血剂

第八章局部止血剂市场：依应用分类

  • 心血管外科
  • 一般外科
  • 肝臟和脾臟撕裂
  • 整形外科
  • 重组手术

第九章外用止血剂市场：依最终用途分类

  • 医院
  • 疗养院
  • 手术中心

第10章美洲局部止血剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区局部止血剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲局部止血剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Ethicon 推出 ETHIZIA 止血密封贴片，临床证明可止血
    • Medcura 的 LifeGel 可吸收手术止血材料获得突破性器械称号
    • Hemostasis 完成对 Feargon Medical Technologies 的收购
  • 战略分析和建议

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-031AB52F47EB

[184 Pages Report] The Topical Hemostat Market size was estimated at USD 2.12 billion in 2023 and expected to reach USD 2.26 billion in 2024, at a CAGR 6.80% to reach USD 3.36 billion by 2030.

A topical hemostat refers to products used to promote hemostasis, a process of stopping bleeding. It is applied directly to a wound or surgical site to prevent excessive blood loss and to encourage clot formation. Topical hemostats are used in various medical situations, from emergency settings and surgical procedures to managing chronic wounds. Topical hemostats contain active substances that accelerate the body's natural clotting process or provide a physical barrier to assist with blood containment. A global rise in surgeries due to an aging population and the elevating incidences of chronic diseases is driving the market. However, the high cost of advanced hemostats and potential complications associated with using certain hemostatic agents can restrict their application and limit their accessibility. Nevertheless, the development of synthetic and bioactive materials that can mimic natural hemostasis and the utilization of nanotechnology in developing advanced hemostatic agents are expected to create lucrative opportunities for the topical hemostat market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.12 billion
Estimated Year [2024] USD 2.26 billion
Forecast Year [2030] USD 3.36 billion
CAGR (%) 6.80%

Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction

Collagen-based topical hemostats are derived from animal collagen, which promotes hemostasis by providing a matrix that facilitates clot formation. Collagen attracts and activates platelets, enhancing the natural coagulation cascade. These products, such as sponges, powders, or films, can come in various forms and are used in different surgical scenarios to control bleeding. Combination topical hemostats incorporate multiple hemostatic agents or mechanisms to enhance their efficacy. They often combine a physical matrix, such as collagen or gelatin, with a procoagulant substance like thrombin or an antibiotic agent to prevent infection. These multi-action products provide simultaneous bleeding control and additional benefits such as infection reduction and are suitable for use in more challenging bleeding situations in surgical settings. Gelatin-based topical hemostats consist of porcine or bovine-derived gelatin and often come as granules, foams, or compressed sponges. These hemostats provide a physical matrix that can absorb blood and concentrate clotting factors at the bleeding site. Gelatin-based hemostats are commonly used in surgical and emergency settings due to their efficacy and ease of application. Oxidized regenerated cellulose-based topical hemostats are made from plant-derived cellulose that is chemically treated to improve its hemostatic properties. These products provide a matrix for clotting and lowering the pH around the wound, which assists in the hemostasis process. Thrombin-based topical hemostats contain thrombin, an enzyme that converts fibrinogen to fibrin, thereby inducing clot formation. These hemostats can be made from human, bovine, or recombinant thrombin and are often applied in conjunction with other materials, including gelatin or collagen pads. This category of hemostatic agent is particularly useful in controlling bleeding when the application of manual pressure is insufficient or impractical.

Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces

Matrix and gel hemostats are bioresorbable agents that work on the principle of providing a physical scaffold to assist in the formation of a stable blood clot. They often contain natural or synthetic substances such as collagen, gelatin, or cellulose. These materials can be combined with thrombin or other active clotting agents to enhance hemostasis. Powder hemostats comprise granular or fluffy materials that adhere to the wound site and assist in clotting through dehydration mechanisms and concentration of clotting factors. Active ingredients such as kaolin, zeolite, or other mineral substances are commonly used. They are particularly advantageous for their ease of application on bleeding surfaces, their usefulness in minimally invasive procedures, and their ability to be applied using applicators or insufflators. Sheet and pad hemostats are usually flat configurations of hemostatic materials designed to be placed directly onto bleeding tissue surfaces. Materials such as oxidized regenerated cellulose (ORC), polyethylene glycol (PEG) polymers, and collagen are commonly used in these formats. They are often preferred for their ease of handling, ability to cut to required shapes, and suitability for providing a mechanical barrier that facilitates clot formation. Sponge hemostats are made from absorbable materials such as gelatin or collagen, which have a porous structure that provides mechanical support for clot formation and a matrix for platelet adhesion and aggregation. These hemostats are commonly used in various surgical procedures and can be applied to oozing surfaces or fill cavities where controlling bleeding is challenging.

Application: Significant usage of topical hemostats in cardiovascular surgery

In cardiovascular surgery, topical hemostats are extensively used to manage bleeding from vascular anastomoses, graft sites, and heart tissues. They are pivotal in promoting hemostasis in high-risk patients or scenarios where precise hemostatic control is critical to prevent excessive blood loss and potential complications such as hematoma formation or reoperation due to bleeding. General surgery involves various procedures where topical hemostats are applied to control bleeding from the surgical site. Whether in open or laparoscopic procedures, these agents reduce intraoperative bleeding. They can be used on various tissues and organs to ensure a drier operative field, which may improve surgical outcomes and shorten operative times. Liver and spleen lacerations often result in significant bleeding due to the vascular nature of these organs. Topical hemostats are crucial in managing bleeding in such cases, providing rapid hemostasis for patient stability. Orthopedic surgeries, particularly those involving joint replacements or bone cutting, can cause significant bleeding. Topical hemostats are used to provide hemostasis at bone surfaces and soft tissue, reducing intraoperative bleeding and potentially minimizing postoperative bruising, hematoma, and improving healing time. In reconstructive surgery, achieving meticulous hemostasis is critical to ensure graft viability and aesthetic outcomes. Topical hemostats are utilized to manage bleeding from both donor and recipient sites, minimizing blood loss and mitigating the risk of postoperative complications such as seroma or hematoma formation, which could compromise the success of the reconstruction.

End-Use: Evolving utilization of topical hemostats in hospitals

Topical hemostats are utilized across various departments of hospitals, such as emergency wards and operating theatres, especially in surgeries involving high bleeding risks, such as cardiovascular, orthopedic, and organ transplantations. Hospitals often require a consistent supply of hemostats due to their broad service in complex and routine surgeries, making them a critical market for manufacturers. Nursing homes adopt topical hemostats, focusing mainly on the geriatric population that may require minor surgical or invasive procedures. Although the volume of use in nursing homes is significantly lower than in hospitals, they still need an array of hemostatic agents to cater to patients who may have heightened bleeding risks due to age-related comorbid conditions. Ambulatory surgical centers, or outpatient surgical centers, are specialized facilities where surgeries that do not require hospital admission. These centers value efficiency and the rapid turnover of surgical cases, often looking for fast-acting topical hemostats to enhance patient throughput and reduce procedure times. The frequency of elective surgeries, such as cosmetic and minimally invasive procedures, at these centers contributes to a steady demand for hemostatic products.

Regional Insights

The Americas exhibit robust growth in the topical hemostat market supported by healthcare infrastructure, high per capita healthcare expenditure, and a focus on advanced surgical procedures. Furthermore, the consumer need, due to the prevalence of surgical procedures and advanced wound management practices with high awareness of the effectiveness of topical hemostats and the readiness of healthcare providers to adopt new technologies, bolster the market growth. Recent investments are primarily channeled toward developing advanced biocompatible and biodegradable hemostats in the Americas. The European Union boasts a sophisticated healthcare system with a strong emphasis on patient safety and high standards of care, which drives the demand for topical hemostats in Europe. The presence of major pharmaceutical companies, coupled with significant investments in research, creates a favorable environment for market growth. On the other hand, in the Middle East and Africa, the market is growing owing to consumers' awareness of advanced medical products and rising demand linked to the development of healthcare infrastructure and the private healthcare sector. Investments and initiatives in these regions focus on capacity building in healthcare services, including adopting effective surgical aids such as topical hemostats. The Asia Pacific region presents a diverse and rapidly expanding topical hemostat market owing to its sizeable populations, growing economies, and investment in healthcare innovation. Furthermore, government backing and a focus on self-sufficiency in healthcare technologies have spurred market growth, leading to a surge in local manufacturing and innovation. The latest patents in the APAC region reflect a drive towards developing innovative hemostatic agents suitable for the local market, considering the economic and healthcare delivery constraints.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Topical Hemostat Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Topical Hemostat Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Topical Hemostat Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences Private Limited, Axio Biosolutions Pvt Ltd, B.Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Betatech Medical, BioCer Entwicklungs-GmbH, Bristol-Myers Squibb Company, Dilon Technologies Inc, GELITA MEDICAL GmbH, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Marine Polymer Technologies, Inc., Medline Industries, LP, Medtrade Products Ltd, Medtronic PLC, Meril Life Sciences Pvt. Ltd, Pfizer Inc., Southmedic Inc., Stryker Corporation, SYMATESE SAS, Takeda Pharmaceutical Company Limited, Teleflex Incorporated, and Zeria Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Topical Hemostat Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Collagen-Based Topical Hemostats
    • Combination Topical Hemostats
    • Gelatin-Based Topical Hemostats
    • Oxidized Regenerated Cellulose-based Topical Hemostats
    • Thrombin-Based Topical Hemostats
  • Formulation
    • Matrix & Gel Hemostats
    • Powder Hemostats
    • Sheet & Pad Hemostats
    • Sponge Hemostats
  • Application
    • Cardiovascular Surgery
    • General Surgery
    • Liver & Spleen Lacerations
    • Orthopedic Surgery
    • Reconstructive Surgery
  • End-Use
    • Hospitals
    • Nursing Homes
    • Surgical Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Topical Hemostat Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Topical Hemostat Market?

3. What are the technology trends and regulatory frameworks in the Topical Hemostat Market?

4. What is the market share of the leading vendors in the Topical Hemostat Market?

5. Which modes and strategic moves are suitable for entering the Topical Hemostat Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising numbers of surgeries due to an aging population and prevalence of chronic diseases
      • 5.1.1.2. Favorable product approval by medical regulators
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with topical hemostat products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D for the introduction of novel topical hemostat
      • 5.1.3.2. Integration of nanotechnology to create more efficient topical hemostats
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations and risk of infection associated with the use of topical hemostats
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning adoption of combination topical hemostats owing to the additional benefits such as infection reduction
    • 5.2.2. Formulation: Proliferating utilization of matrix and gel hemostats owing to their ability to conform to irregular wound surfaces
    • 5.2.3. Application: Significant usage of topical hemostats in cardiovascular surgery
    • 5.2.4. End-Use: Evolving utilization of topical hemostats in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Topical Hemostat Market, by Product

  • 6.1. Introduction
  • 6.2. Collagen-Based Topical Hemostats
  • 6.3. Combination Topical Hemostats
  • 6.4. Gelatin-Based Topical Hemostats
  • 6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
  • 6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Formulation

  • 7.1. Introduction
  • 7.2. Matrix & Gel Hemostats
  • 7.3. Powder Hemostats
  • 7.4. Sheet & Pad Hemostats
  • 7.5. Sponge Hemostats

8. Topical Hemostat Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Surgery
  • 8.3. General Surgery
  • 8.4. Liver & Spleen Lacerations
  • 8.5. Orthopedic Surgery
  • 8.6. Reconstructive Surgery

9. Topical Hemostat Market, by End-Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Nursing Homes
  • 9.4. Surgical Centers

10. Americas Topical Hemostat Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Topical Hemostat Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Topical Hemostat Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Ethicon Introduces ETHIZIA Hemostatic Sealing Patch, Clinically Proven to Stop Disruptive Bleeding
    • 13.3.2. Medcura Receives Breakthrough Device Designation for its LifeGel Absorbable Surgical Hemostat
    • 13.3.3. Hemostasis Closes Acquisition of Fiagon Medical Technologies
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. TOPICAL HEMOSTAT MARKET DYNAMICS
  • FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MATRIX & GEL HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SHEET & PAD HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPONGE HEMOSTATS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LIVER & SPLEEN LACERATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 134. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 142. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 158. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 174. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 198. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 224. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 232. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 240. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 248. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 256. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 264. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 280. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 288. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 296. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 304. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 312. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 313. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 316. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 317. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 320. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 322. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 324. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 328. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 332. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 337. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 338. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 339. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 340. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 341. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 344. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 345. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 346. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 347. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 350. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 351. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 352. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 356. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 360. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 361. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 362. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 363. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 364. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 365. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLIO